two new light-activated drugs

There's lots of excitement about two new light-activated drugs. They are coming to the market now in the U.S...and a little later in Canada.

Physicians provide these new phototherapies in their office.

Visudyne (verteporfin, CibaVision/QLT PhotoTherapeutics) is for the WET form of macular degeneration. The "wet" form is less common than the "dry" form...but it's more severe.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote